SLC44A1 and pancreatic neoplasm: KIAA1217, SLC44A1, INPP5B, and SDK1 were reversely correlated with some miRNAs not affecting patient survival (Fig. 6E), which shows these are potential therapeutic targets for pancreatic cancer.